Complete blood count parameters and inflammation-related biomarkers in patients with colorectal carcinoma.

IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Martha Koržinek, Ivana Ćelap, Marija Fabijanec, Tena Žanić, Neven Ljubičić, Neven Baršić, Donatella Verbanac, Karmela Barišić, Marija Grdić Rajković
{"title":"Complete blood count parameters and inflammation-related biomarkers in patients with colorectal carcinoma.","authors":"Martha Koržinek, Ivana Ćelap, Marija Fabijanec, Tena Žanić, Neven Ljubičić, Neven Baršić, Donatella Verbanac, Karmela Barišić, Marija Grdić Rajković","doi":"10.2478/acph-2024-0036","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this study was to determine whether there are differences in complete blood count parameters (CBC) and inflammation-related biomarkers, MPV/PC, PLR, NLR, LWR, LMR, NMR, and LCR, among patients with colorectal carcinoma (CRC) and patients with colorectal adenomas. The study included 155 patients who were divided into two groups according to histopathological analysis - 74 adenomas patients and 81 CRC patients. A routine examination of CBC was conducted on Sysmex XN1000 whereas CRP was measured on Alinity ci-series. Statistical analysis was performed by ROC curve analysis using MedCalc Statistical Software. In CRC patients, hemoglobin concentration, hematocrit, MCV, MCH, and MCHC were lower, while RDW was higher (<i>p</i> < 0.001), compared to patients with adenomas. Total leukocyte count (<i>p</i> = 0 .006), absolute neutrophils (<i>p</i> = 0.005), and absolute monocytes (<i>p</i> = 0.007) were lower while relative eosinophils (<i>p</i> = 0.001) and relative basophils (<i>p</i> = 0.001) were higher in CRC patients. Platelet count (<i>p</i> < 0.001) was significantly higher and MPV (<i>p</i> = 0.003) was significantly lower in CRC patients. Furthermore, MPV/PC (<i>p</i> < 0.001) was significantly lower and PLR (<i>p</i> < 0.001) was significantly higher in CRC. Moreover, Receiver Operating Characteristic (ROC) analysis revealed poor diagnostic accuracy, for all tested parameters (AUC was 0.7 or less). PC, MPV, MPV/PC, and PLR were significantly different between study groups, but ROC analysis revealed poor diagnostic accuracy. Lower hemo globin levels in CRC patients are possibly due to more frequent and excessive bleeding. Higher levels of basophils and eosinophils in CRC patients are indicators of inflammatory reaction, which is linked to CRC.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Pharmaceutica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2478/acph-2024-0036","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of this study was to determine whether there are differences in complete blood count parameters (CBC) and inflammation-related biomarkers, MPV/PC, PLR, NLR, LWR, LMR, NMR, and LCR, among patients with colorectal carcinoma (CRC) and patients with colorectal adenomas. The study included 155 patients who were divided into two groups according to histopathological analysis - 74 adenomas patients and 81 CRC patients. A routine examination of CBC was conducted on Sysmex XN1000 whereas CRP was measured on Alinity ci-series. Statistical analysis was performed by ROC curve analysis using MedCalc Statistical Software. In CRC patients, hemoglobin concentration, hematocrit, MCV, MCH, and MCHC were lower, while RDW was higher (p < 0.001), compared to patients with adenomas. Total leukocyte count (p = 0 .006), absolute neutrophils (p = 0.005), and absolute monocytes (p = 0.007) were lower while relative eosinophils (p = 0.001) and relative basophils (p = 0.001) were higher in CRC patients. Platelet count (p < 0.001) was significantly higher and MPV (p = 0.003) was significantly lower in CRC patients. Furthermore, MPV/PC (p < 0.001) was significantly lower and PLR (p < 0.001) was significantly higher in CRC. Moreover, Receiver Operating Characteristic (ROC) analysis revealed poor diagnostic accuracy, for all tested parameters (AUC was 0.7 or less). PC, MPV, MPV/PC, and PLR were significantly different between study groups, but ROC analysis revealed poor diagnostic accuracy. Lower hemo globin levels in CRC patients are possibly due to more frequent and excessive bleeding. Higher levels of basophils and eosinophils in CRC patients are indicators of inflammatory reaction, which is linked to CRC.

结直肠癌患者的全血细胞计数参数和炎症相关生物标记物。
本研究旨在确定结直肠癌(CRC)患者和结直肠腺瘤患者的全血细胞计数参数(CBC)和炎症相关生物标志物 MPV/PC、PLR、NLR、LWR、LMR、NMR 和 LCR 是否存在差异。研究包括 155 名患者,根据组织病理学分析将他们分为两组--74 名腺瘤患者和 81 名 CRC 患者。CBC 的常规检查在 Sysmex XN1000 上进行,而 CRP 则在 Alinity ci-series 上测量。统计分析采用 MedCalc 统计软件进行 ROC 曲线分析。与腺瘤患者相比,CRC 患者的血红蛋白浓度、血细胞比容、MCV、MCH 和 MCHC 较低,而 RDW 较高(p < 0.001)。CRC 患者的白细胞总数(p = 0 .006)、中性粒细胞绝对数(p = 0.005)和单核细胞绝对数(p = 0.007)较低,而嗜酸性粒细胞相对数(p = 0.001)和嗜碱性粒细胞相对数(p = 0.001)较高。CRC 患者的血小板计数(p < 0.001)明显较高,MPV(p = 0.003)明显较低。此外,在 CRC 患者中,MPV/PC(p < 0.001)明显较低,PLR(p < 0.001)明显较高。此外,受试者操作特征(ROC)分析表明,所有测试参数的诊断准确性都很低(AUC 为 0.7 或更低)。研究组间的 PC、MPV、MPV/PC 和 PLR 有显著差异,但 ROC 分析显示诊断准确性较差。CRC 患者的血红蛋白水平较低,这可能是由于出血次数较多、出血量较大所致。CRC 患者嗜碱性粒细胞和嗜酸性粒细胞水平较高,这表明炎症反应与 CRC 有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Pharmaceutica
Acta Pharmaceutica PHARMACOLOGY & PHARMACY-
CiteScore
5.20
自引率
3.60%
发文量
20
审稿时长
>12 weeks
期刊介绍: AP is an international, multidisciplinary journal devoted to pharmaceutical and allied sciences and contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice. Topics covered are: analytics, biochemistry, biopharmaceutics, biotechnology, cell biology, cell cultures, clinical pharmacy, drug design, drug delivery, drug disposition, drug stability, gene technology, medicine (including diagnostics and therapy), medicinal chemistry, metabolism, molecular modeling, pharmacology (clinical and animal), peptide and protein chemistry, pharmacognosy, pharmacoepidemiology, pharmacoeconomics, pharmacodynamics and pharmacokinetics, protein design, radiopharmaceuticals, and toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信